Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 2, Pages 428
Publisher
MDPI AG
Online
2020-02-25
DOI
10.3390/cells9020428
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brain-Derived Neurotrophin and TrkB in Head and Neck Squamous Cell Carcinoma
- (2019) József Dudás et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adhesion Deregulation in Acute Myeloid Leukaemia
- (2019) Alicja Gruszka et al. Cells
- MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
- (2019) Lu Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MITA1, a novel energy stress-inducible lncRNA, promotes hepatocellular carcinoma metastasis
- (2019) Meilin Ma et al. HEPATOLOGY
- EMT and Cancer: More Than Meets the Eye
- (2019) Rik Derynck et al. DEVELOPMENTAL CELL
- Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease
- (2019) Varsha Prakash et al. Nature Communications
- Pleiotropic Effects of Epithelial Mesenchymal Crosstalk on Head and Neck Cancer: EMT and beyond
- (2019) T. B. Steinbichler et al. Cancer Microenvironment
- Truncation of MYH8 tail in AML: a novel prognostic marker with increase cell migration and epithelial–mesenchymal transition utilizing RAF/MAPK pathway
- (2019) Hyejoo Park et al. CARCINOGENESIS
- Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study
- (2019) Serena Di Cosimo et al. PLoS One
- Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma
- (2019) Oscar Arrieta et al. JAMA Oncology
- Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity
- (2019) Xiao-Guang Yang et al. Frontiers in Oncology
- A gene regulatory network to control EMT programs in development and disease
- (2019) Hassan Fazilaty et al. Nature Communications
- Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion
- (2019) Yuanyuan Jiang et al. CANCER LETTERS
- Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial
- (2019) Robert Coleman et al. LANCET ONCOLOGY
- Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy
- (2019) Jeffrey C. Thompson et al. LUNG CANCER
- A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
- (2018) Amita Patnaik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway
- (2018) Yingying Jin et al. EXPERIMENTAL CELL RESEARCH
- Nerve Growth Factor (NGF)—Receptor Survival Axis in Head and Neck Squamous Cell Carcinoma
- (2018) József Dudás et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC
- (2018) Joel P. Joseph et al. ORAL ONCOLOGY
- Involvement of epithelial-mesenchymal transition in liver fibrosis
- (2018) Ning Li et al. Saudi Journal of Gastroenterology
- CD47 is a direct target of SNAI1 and ZEB1 and its blockade activates the phagocytosis of breast cancer cells undergoing EMT
- (2018) Muhammad Zaeem Noman et al. OncoImmunology
- Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction
- (2018) Rui Feng et al. Cell Communication and Signaling
- EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer
- (2018) Li Wang et al. Nature Communications
- A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma
- (2018) Theodoros N. Teknos et al. INVESTIGATIONAL NEW DRUGS
- CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer
- (2018) Zhenyu Zhou et al. CELLULAR ONCOLOGY
- The STAT3/Slug Axis Enhances Radiation-Induced Tumor Invasion and Cancer Stem-like Properties in Radioresistant Glioblastoma
- (2018) Jang-Chun Lin et al. Cancers
- Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis
- (2017) Elena Andreucci et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Chronic Resveratrol Treatment Inhibits MRC5 Fibroblast SASP-Related Protumoral Effects on Melanoma Cells
- (2017) Beatrice Menicacci et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- EMT and inflammation: inseparable actors of cancer progression
- (2017) Meggy Suarez-Carmona et al. Molecular Oncology
- Context-specific roles of EMT programmes in cancer cell dissemination
- (2017) M. Angela Nieto NATURE CELL BIOLOGY
- A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion
- (2017) Anna Labernadie et al. NATURE CELL BIOLOGY
- The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
- (2017) Angela M. Krebs et al. NATURE CELL BIOLOGY
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma
- (2017) H Sun et al. ONCOGENE
- Separation of cell survival, growth, migration, and mesenchymal transdifferentiation effects of fibroblast secretome on tumor cells of head and neck squamous cell carcinoma
- (2017) Veronika Maria Metzler et al. TUMOR BIOLOGY
- KLF7 overexpression in human oral squamous cell carcinoma promotes migration and epithelial-mesenchymal transition
- (2017) Xiaojun Ding et al. Oncology Letters
- Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells
- (2017) Zheng Cao et al. Oncotarget
- IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma
- (2017) Chunbao Zang et al. Oncotarget
- Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells
- (2017) Teresa Bernadette Steinbichler et al. Oncotarget
- Ectopic Expression of Snail and Twist in Ph+ Leukemia Cells Upregulates CD44 Expression and Alters Their Differentiation Potential
- (2017) Noa Kidan et al. Journal of Cancer
- The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200
- (2017) Muhammad Zaeem Noman et al. OncoImmunology
- EMT, cell plasticity and metastasis
- (2016) Christine L. Chaffer et al. CANCER AND METASTASIS REVIEWS
- MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome
- (2016) Vaia Stavropoulou et al. CANCER CELL
- Acute myeloid leukemia in the vascular niche
- (2016) Christopher R. Cogle et al. CANCER LETTERS
- Melanoma Cells Block PEDF Production in Fibroblasts to Induce the Tumor-Promoting Phenotype of Cancer-Associated Fibroblasts
- (2016) Nkechiyere G. Nwani et al. CANCER RESEARCH
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer
- (2016) Elisabet Cuyàs et al. CELL CYCLE
- Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases
- (2016) Nancy Chan et al. CLINICAL CANCER RESEARCH
- Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma
- (2016) Y. Lou et al. CLINICAL CANCER RESEARCH
- Therapy-Induced Cellular Senescence Induces Epithelial-to-Mesenchymal Transition and Increases Invasiveness in Rectal Cancer
- (2016) Joana Tato-Costa et al. Clinical Colorectal Cancer
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
- (2016) Bowen Du et al. MOLECULES
- MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features
- (2016) Ruma Dey Ghosh et al. Scientific Reports
- Silibinin attenuates ionizing radiation-induced pro-angiogenic response and EMT in prostate cancer cells
- (2015) Dhanya K. Nambiar et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis
- (2015) M. Ruscetti et al. CANCER RESEARCH
- Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer
- (2015) Shusuke Toden et al. CARCINOGENESIS
- TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma
- (2015) Naoki Oshimori et al. CELL
- IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review)
- (2015) XINXIN LONG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974
- (2015) Jonathan D Boone et al. LABORATORY INVESTIGATION
- Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling
- (2015) D. K. Nambiar et al. MOLECULAR CANCER THERAPEUTICS
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
- (2015) Kari R. Fischer et al. NATURE
- Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
- (2015) Xin Ye et al. NATURE
- Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease
- (2015) M Teresa Grande et al. NATURE MEDICINE
- Inflammatory mediators, tumor necrosis factor-α and interferon-γ, induce EMT in human PTC cell lines
- (2015) NANNAN LV et al. Oncology Letters
- Tumor-associated fibroblast-conditioned medium induces CDDP resistance in HNSCC cells
- (2015) Teresa Bernadette Steinbichler et al. Oncotarget
- Transient SNAIL1 Expression Is Necessary for Metastatic Competence in Breast Cancer
- (2014) H. D. Tran et al. CANCER RESEARCH
- Decoding the Knots of Initiation of Oncogenic Epithelial-Mesenchymal Transition in Tumor Progression
- (2014) Pengda Guo et al. CURRENT CANCER DRUG TARGETS
- Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer
- (2014) Jordi Rodón et al. INVESTIGATIONAL NEW DRUGS
- Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
- (2014) John C. Morris et al. PLoS One
- Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis
- (2014) Zhongquan Zhao et al. PLoS One
- Doxycycline Inducible Kruppel-Like Factor 4 Lentiviral Vector Mediates Mesenchymal to Epithelial Transition in Ovarian Cancer Cells
- (2014) Zixuan Chen et al. PLoS One
- Epithelial-Mesenchymal Transition and Drug Resistance: Role, Molecular Mechanisms, and Therapeutic Strategies
- (2014) Hua Sui et al. Oncology Research and Treatment
- A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients
- (2013) Masashi Kanai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The relevance of the TGF-β Paradox to EMT-MET programs
- (2013) Chevaun D. Morrison et al. CANCER LETTERS
- Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells
- (2013) Jian Guan et al. CANCER LETTERS
- Understanding the functions of tumor stroma in resistance to ionizing radiation: Emerging targets for pharmacological modulation
- (2013) Cyrus Chargari et al. DRUG RESISTANCE UPDATES
- Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition
- (2013) JAMES W. ANTOON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Sources of myofibroblasts in kidney fibrosis: All answers are correct, however to different extent!
- (2013) Tobias M. Ballhause et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Epithelial-Mesenchymal Transition Induces an Antitumor Immune Response Mediated by NKG2D Receptor
- (2013) A. Lopez-Soto et al. JOURNAL OF IMMUNOLOGY
- A p21-ZEB1 Complex Inhibits Epithelial-Mesenchymal Transition through the MicroRNA 183-96-182 Cluster
- (2013) X. L. Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Slug is a key mediator of hypoxia induced cadherin switch in HNSCC: Correlations with poor prognosis
- (2013) Jiali Zhang et al. ORAL ONCOLOGY
- iTRAQ-Based Proteomic Analysis of Polyploid Giant Cancer Cells and Budding Progeny Cells Reveals Several Distinct Pathways for Ovarian Cancer Development
- (2013) Shiwu Zhang et al. PLoS One
- Correction: Klf4 Is a Transcriptional Regulator of Genes Critical for EMT, Including Jnk1 (Mapk8)
- (2013) Neha Tiwari et al. PLoS One
- The potential for targeting extracellular LOX proteins in human malignancy
- (2013) Janine Erler et al. OncoTargets and Therapy
- EMT and MET in Metastasis: Where Are the Cancer Stem Cells?
- (2012) Thomas Brabletz CANCER CELL
- Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: Potential role of hypoxia
- (2012) Delphine Tamara Marie-Egyptienne et al. CANCER LETTERS
- Curcumin targets fibroblast–tumor cell interactions in oral squamous cell carcinoma
- (2012) József Dudás et al. EXPERIMENTAL CELL RESEARCH
- Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance
- (2012) James W. Antoon et al. Scientific Reports
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma
- (2011) Ke-Jun Nan INTERNATIONAL JOURNAL OF ONCOLOGY
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
- (2011) M Saxena et al. Cell Death & Disease
- Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
- (2010) Tzu-Hua Chang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
- (2010) Alejandro Vazquez-Martin et al. CELL CYCLE
- The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer
- (2010) Roy M. Bremnes et al. Journal of Thoracic Oncology
- TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma
- (2010) M E Kupferman et al. ONCOGENE
- Fibroblasts produce brain-derived neurotrophic factor and induce mesenchymal transition of oral tumor cells
- (2010) József Dudás et al. ORAL ONCOLOGY
- Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
- (2010) J. H. Taube et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer
- (2010) Thomas W. Flaig et al. PROSTATE
- Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse
- (2010) Ira Skvortsova et al. RADIOTHERAPY AND ONCOLOGY
- Inflammation and EMT: an alliance towards organ fibrosis and cancer progression
- (2009) Jose Miguel López-Novoa et al. EMBO Molecular Medicine
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
- (2009) S. G. Aller et al. SCIENCE
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
- (2008) Jing Yang et al. DEVELOPMENTAL CELL
- A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition
- (2008) M. Beltran et al. GENES & DEVELOPMENT
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search